Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $862,561 - $1.28 Million
-100,649 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$8.12 - $13.12 $12,813 - $20,703
-1,578 Reduced 1.54%
100,649 $1.24 Million
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $677,208 - $1.36 Million
101,227 Added 10122.7%
102,227 $918,000
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $16,680 - $22,070
1,000 New
1,000 $17,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.